claim: redirect receives fda eua on 8/15
evidence_1: while fda has seen variable performance in tests using saliva, yale school of public health submitted data with its eua request from which the fda determined that yales test meets the criteria for emergency authorization when used to test saliva samples for sars-cov-2, the virus that causes covid-19 infection.", "additionally, the salivadirect methodology has been validated and authorized for use with different combinations of commonly used reagents and instruments, meaning the test could be used broadly in most high-complexity labs.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "most accurate of currently available saliva tests at about 90% accuracy.")